Encompass Health (NYSE:EHC) Price Target Raised to $122.00 at KeyCorp

Encompass Health (NYSE:EHC) had its price objective upped by KeyCorp from $120.00 to $122.00 in a report published on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

A number of other research analysts have also weighed in on the company. Royal Bank of Canada restated an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Wednesday, April 16th. Finally, Barclays raised their price target on shares of Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a research report on Friday. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus target price of $110.88.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $113.33 on Friday. Encompass Health has a twelve month low of $82.09 and a twelve month high of $114.38. The stock’s 50 day moving average is $100.08 and its 200-day moving average is $98.51. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The firm has a market capitalization of $11.41 billion, a price-to-earnings ratio of 25.41, a PEG ratio of 2.31 and a beta of 0.87.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Sell-side analysts forecast that Encompass Health will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date of this dividend was Tuesday, April 1st. Encompass Health’s dividend payout ratio is currently 15.25%.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 2.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Encompass Health

Large investors have recently added to or reduced their stakes in the company. KBC Group NV boosted its position in Encompass Health by 6.1% during the first quarter. KBC Group NV now owns 4,557 shares of the company’s stock worth $462,000 after purchasing an additional 263 shares during the period. Allspring Global Investments Holdings LLC boosted its holdings in Encompass Health by 51.4% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 69,231 shares of the company’s stock worth $7,012,000 after buying an additional 23,518 shares during the period. Highland Capital Management LLC purchased a new position in Encompass Health in the 1st quarter valued at approximately $206,000. Sequoia Financial Advisors LLC raised its holdings in Encompass Health by 6.7% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company’s stock valued at $276,000 after acquiring an additional 172 shares during the period. Finally, Longboard Asset Management LP purchased a new stake in shares of Encompass Health during the first quarter worth $206,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.